Children in low-income families who get extra help building social skills before kindergarten may behave better and get higher grades than their peers, a small study suggests.
Many acute medical conditions can be treated without admitting patients to the hospital, with no increased risk and, in some cases, higher patient satisfaction, according to a new review.
As the investigation into Prince's death homes in on the source of the fatal fentanyl, some observers are suggesting that the United States explore a lifesaving strategy used in Europe: services that check addicts' drug supplies to see if they are safe.
Jamie-Lynn Sigler kept her multiple sclerosis (MS) diagnosis secret for nearly 15 years, but now “The Sopranos” actress is speaking publicly about her journey with the condition to raise awareness and inspire other people like herself to find support.
Top U.S. health officials said on Monday the long delay in getting Congress to approve funding to fight the Zika virus came at a heavy cost in dealing with what they called a serious public health threat.
Breakfast is hailed as the most important meal of the day: It jump-starts the metabolism, reduces afternoon hunger cravings, and provides the energy necessary for a long day.
Japanese police are investigating the poisoning deaths of two elderly patients at a hospital near Tokyo, the latest in a spate of deaths on the same floor of the facility to arouse suspicion.
The first results of a study out of the UK are raising the tantalizing possibility that researchers have figured not just how to treat HIV but how to actually cure it.
Yoshinori Ohsumi, a 71-year-old Japanese scientist and professor at the Tokyo Institute of Technology, is this year's winner of the Nobel Prize in medicine.
Japanese biologist Yoshinori Ohsumi won the Nobel Prize in medicine on Monday for discoveries on how cells break down and recycle content, a garbage disposal system that scientists hope to harness in the fight against cancer, Alzheimer's and other diseases.
Spectral Medical Inc said its experimental treatment for sepsis - a common, oft-deadly complication of infection - failed a late-stage study, stymieing the company's plans to bring to market the first FDA-approved device for the condition.